Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study

Journal of Alzheimer's Disease : JAD
Pratishtha ChatterjeeRalph N Martins

Abstract

Aberrant lipid metabolism has been implicated in sporadic Alzheimer's disease (AD). The current study investigated plasma phospholipid and sphingolipid profiles in individuals carrying PSEN1 mutations responsible for autosomal dominant AD (ADAD). Study participants evaluated were from the Perth and Melbourne sites of the Dominantly Inherited Alzheimer Network (DIAN) study. Plasma phospholipid and sphingolipid profiles were measured using liquid chromatography coupled with mass spectrometry in 20 PSEN1 mutation carriers (MC; eight of whom were symptomatic and twelve asymptomatic, based on Clinical Dementia Rating scores) and compared with six non carriers (NC) using linear mixed models. Further, AD gold standard biomarker data obtained from the DIAN database were correlated with lipid species significantly altered between MC and NC, using Spearman's correlation coefficient. One-hundred and thirty-nine plasma phospholipid and sphingolipid species were measured. Significantly altered species in MC compared to NC primarily belonged to choline and ethanolamine containing phospholipid classes and ceramides. Further phosphatidylcholine species (34:6, 36:5, 40:6) correlated with cerebrospinal fluid tau (p <  0.05), and plasmalogen etha...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·R M NitschR J Wurtman
Aug 1, 1995·Progress in Neurobiology·H Katsuki, S Okuda
Apr 1, 1997·Trends in Neurosciences·J Hardy
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER
Oct 29, 2003·Chemistry and Physics of Lipids·William Stillwell, Stephen R Wassall
Oct 18, 2005·Nature Cell Biology·Marcus O W GrimmTobias Hartmann
May 11, 2006·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Akhlaq A Farooqui, Lloyd A Horrocks
Jun 17, 2006·International Review of Psychiatry·Michelle M Mielke, C G Lyketsos
Oct 10, 2006·Biochimica Et Biophysica Acta·Karin GorgasWilhelm W Just
Dec 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Natalie LandmanTae-Wan Kim
May 6, 2008·Neurobiology of Aging·Michelle M MielkeMichelle C Carlson
Sep 4, 2010·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Michelle M MielkeConstantine G Lyketsos
Aug 16, 2011·Journal of Alzheimer's Disease : JAD·Michelle M MielkeConstantine G Lyketsos
Dec 3, 2011·The Journal of Biological Chemistry·Robin B ChanGilbert Di Paolo
Feb 2, 2012·Alzheimer's Research & Therapy·Paul L Wood
Jul 13, 2012·The New England Journal of Medicine·Randall J BatemanUNKNOWN Dominantly Inherited Alzheimer Network
Apr 23, 2013·Neurobiology of Aging·Wei Ling Florence LimRalph Nigel Martins
Jul 23, 2013·Journal of Lipid Research·Alfred N FontehMichael G Harrington
Sep 18, 2013·Neurobiology of Aging·Luke WhileyUNKNOWN AddNeuroMed Consortium
Mar 13, 2014·Nature Medicine·Mark MapstoneHoward J Federoff
Jun 15, 2014·Neurology·Davis C RymanUNKNOWN Dominantly Inherited Alzheimer Network

❮ Previous
Next ❯

Citations

May 13, 2017·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Weiwei LinXiaomei Ling
Dec 22, 2016·Current Opinion in Psychiatry·Matthew W WongPerminder S Sachdev
Feb 27, 2018·Journal of Alzheimer's Disease : JAD·Fabian DorningerJohannes Berger
Jan 22, 2019·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Yufei WuKejin Zhang
May 1, 2019·American Journal of Physiology. Endocrinology and Metabolism·Günter A MüllerMatthias H Tschöp
Oct 9, 2019·Molecular Psychiatry·Stefan R BornsteinRichard Straube
Jun 1, 2020·Journal of Alzheimer's Disease : JAD·Wei Ling Florence LimUNKNOWN AIBL research group
Sep 10, 2019·Frontiers in Neurology·Matthew Wai Kin WongAnne Poljak
Sep 19, 2017·Journal of Alzheimer's Disease : JAD·Pilar Martinez Martinez, Michelle M Mielke
Mar 30, 2019·Molecular Brain·Henrik Zetterberg, Samantha C Burnham
Apr 8, 2017·Scientific Reports·Kathryn GoozeeRalph N Martins
Mar 1, 2017·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Matthew W WongPerminder S Sachdev
Jan 22, 2021·Annals of Clinical and Translational Neurology·Karthick NatarajanCaroline Graff
Apr 18, 2020·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Angélica María Sabogal-GuáquetaGloria Patricia Cardona-Gómez
Apr 30, 2021·Ageing Research Reviews·Harald HampelUNKNOWN Alzheimer Precision Medicine Initiative (APMI)
May 27, 2021·ACS Chemical Neuroscience·Alberto Llorente-OvejeroRafael Rodríguez-Puertas
Sep 29, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jing GuJialin Gao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.